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Jerome Sarris1,2*, Adrienne O’Neil3,4, Carolyn E Coulson3, Isaac Schweitzer1 and Michael Berk1,3,5,6Abstract
The prevalence of depression appears to have increased over the past three decades. While this may be an artefact
of diagnostic practices, it is likely that there are factors about modernity that are contributing to this rise. There is
now compelling evidence that a range of lifestyle factors are involved in the pathogenesis of depression. Many of
these factors can potentially be modified, yet they receive little consideration in the contemporary treatment of
depression, where medication and psychological intervention remain the first line treatments. “Lifestyle Medicine”
provides a nexus between public health promotion and clinical treatments, involving the application of
environmental, behavioural, and psychological principles to enhance physical and mental wellbeing. This may also
provide opportunities for general health promotion and potential prevention of depression. In this paper we
provide a narrative discussion of the major components of Lifestyle Medicine, consisting of the evidence-based
adoption of physical activity or exercise, dietary modification, adequate relaxation/sleep and social interaction, use
of mindfulness-based meditation techniques, and the reduction of recreational substances such as nicotine, drugs,
and alcohol. We also discuss other potential lifestyle factors that have a more nascent evidence base, such as
environmental issues (e.g. urbanisation, and exposure to air, water, noise, and chemical pollution), and the
increasing human interface with technology. Clinical considerations are also outlined. While data supports that
some of these individual elements are modifiers of overall mental health, and in many cases depression, rigorous
research needs to address the long-term application of Lifestyle Medicine for depression prevention and
management. Critically, studies exploring lifestyle modification involving multiple lifestyle elements are needed.
While the judicious use of medication and psychological techniques are still advocated, due to the complexity of
human illness/wellbeing, the emerging evidence encourages a more integrative approach for depression, and an
acknowledgment that lifestyle modification should be a routine part of treatment and preventative efforts.
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While modernity has provided multiple technological and
medical advances including increased life-expectancy, it
has come at a cost, in that a range of lifestyle issues are
now negatively affecting our mental health [1]. As Hidaka
[1] and Walsh [2] comment, in Western society people are
increasingly becoming more sedentary and eating a poorer
diet than previous generations. This, in combination with
sleep/wake cycle pressures, substance misuse, and psycho-
social factors such as more competition and time pressure,
social isolation and less intimate engagement with the
family unit, may exert a cost on mental health. Further,* Correspondence: jsarris@unimelb.edu.au
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reproduction in any medium, provided the orthe combination of stress, fatigue, inactivity, and sleep
deficiency in people who are “time-poor”, may advance
obesity, and this in turn may promote a sedentary life
with potential for resultant depression.
Due to the afore-mentioned challenges of modern
urbanity, there is now the need to consider a “Lifestyle
Medicine” approach for the potential prevention, promo-
tion and management of depression. While medication
and psychological interventions are first-line treatments
for depression, Lifestyle Medicine offers a potentially safe
and low-cost option for augmenting the management of
the condition. While the evidence base remains patchy,
many lifestyle or environmental factors are mutable and
can provide the basis of practical interventions for the
management of depression (summarised in Table 1).
Lifestyle Medicine involves the application of environmen-
tal, behavioural, and psychological principles to enhancetd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
Table 1 Lifestyle medicine for depression
Lifestyle element Evidence level Cost Comment
Diet CS, LO Moderate expense Relationship found between dietary quality and depression; RCTs now
required to validate
PA/Exercise CS*, LO*, CTs Inexpensive Strong evidence of efficacy for improving mood




CTs Inexpensive Evidence supports relaxation techniques (especially with a mindfulness
component) in improving mood
Sleep CS, LO, CTs No expense Strong causal link between sleep amount and quality, and depression risk
Environment CS, LO, CTs Potentially not adjustable Association between reduction of pollution and mood; CTs showing NAT
improves mood
Socialization CS, LO No expense Strong association between social support/networks and mental health
Animal/Pet therapy CS, CTs Moderate expense Studies support the psychological benefits of animals and pets
Vices (smoking, alcohol) CS, LO Potential to save money Association between smoking and alcohol, and depressed mood
CS = Cross-sectional, OB = Observational Study, LO = Longitudinal, CTs - Clinical Trials, NAT = Nature-Assisted Therapy, PA = Physical Activity, Data assessing the
relationship between exercise and depression has revealed mixed outcomes.
*Data assessing the relationship between exercise and depression has revealed mixed outcomes.
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potentially preventative approach to illness [3]. This
may involve modification of: diet; physical activity and
exercise; relaxation and sleep-wake cycles; recreation
and work-rest balance; and minimisation/avoidance of
smoking, alcohol or illicit substances, in addition to the
use of mindfulness-based meditation techniques [2]. Al-
though the evidence base remains in its infancy, environ-
mental issues are also considerations, such as reducing
exposure to pollution (air, water, noise, and chemicals)
and increasing time spent in nature, and are areas of
current investigation. Activity scheduling such as encour-
aging engagement in meaningful activities and adequate
social contact [1] is additionally of value. Further, Lifestyle
Medicine may involve the application of clinical psycho-
logical techniques, insofar as motivational and behavioural
factors are intrinsic to people trying to embrace lifestyle
changes [3].
While lifestyle modification has been recognised by
practitioners for centuries as a means by which to im-
prove health outcomes, the field of “Lifestyle Medicine”,
particularly in the context of mental health, is a rela-
tively new field. While papers have discussed its broader
application on health and in particular prevention of
chronic disease and cardiovascular/metabolic conditions,
little attention has been given to its application for mental
health, and in particular depression, which is predicted to
be the predominant cause of disability in the developed
world [4], and is being argued as one of the prevalent
non-communicable disorders [5]. Some studies show
that patients with sub-threshold depression rate lifestyle
or psychosocial approaches as strategies that are most
helpful in improving their mood [6], while patients with
clinical depression have rated exercise as the most
effective intervention [7].There is a heuristic theoretical framework explaining
why the modern lifestyle may be impacting mental health.
Obesity [8], poor diet [9], poor/decreased sleep [10],
exposure to chemicals and pollutants [11], and high
stress levels [12], may potentially disrupt the hypothal-
amic pituitary adrenal axis, increase cortisol and in-
crease low-grade systemic inflammation and oxidative
stress. Both neuroendocrine disruption and inflammation
have been linked to the aetiology of depression [13,14].
Specifically, increased levels of proinflammatory cytokines,
interferon gamma and neopterin, reactive oxygen and ni-
trogen species and damage by oxidative and nitrosative
stress, in combination with lowered levels of antioxidants,
may potentially damage mitochondria and mitochondrial
DNA; this may result in neurodegeneration and reduced
neurogenesis [14].
This opinion paper aims to provide a context for Life-
style Medicine by providing an overview of the lifestyle
factors that are linked with depression risk before explor-
ing the evidence and clinical application of modifying
these elements. The paper firstly explores data for which
there is sound evidentiary support (diet, physical activity
and exercise, mindfulness meditation, management of rec-
reational substance misuse, sleep, and social interaction),
and then touches on lifestyle and environmental elements
that have nascent data and are subject to confirmatory
investigation (greenspace and pollutant exposure, hobbies
and relaxation, and animal/pet therapy).
Review
Lifestyle elements with supportive data
Diet
Major dietary changes have occurred across the globe in
the past century [15]. Specifically, there has been a shift
in the common dietary patterns of Western societies to
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refined sugar. In fact, nutrient-insufficient and energy-
dense foods now contribute approximately 30% to the
daily dietary intakes of American adults [16]. Over recent
years, evidence has emerged to suggest that poor diet may
be a risk factor for the onset of depression. While the
strength and nature of this relationship remains unclear,
not only have cross-sectional data shown that poor dietary
patterns and quality are associated with depressed mood
and anxiety [9,17-25], but prospective studies have further
provided support for the predictive role of diet in the
development of mental disorders.
Recent prospective data from the ongoing Whitehall II
cohort study of middle-aged office workers in Britain (n =
3486) has revealed an increased risk of incident depression
over five years for people consuming a Western style diet-
ary pattern. Moreover, a reduced risk for those eating a
whole foods diet pattern was observed [26]. Another re-
cent prospective study, this time comprising Australian
adolescents, has provided comparable data. An examin-
ation of examined 3040 Australian adolescents (aged
11–18) found that diet quality was associated with ado-
lescent mental health both cross-sectionally and pro-
spectively [27], where deterioration in diet quality was
associated with poorer psychological functioning. Import-
antly, improvements in mental health were also mirrored
by improvements in diet quality.
The notion that dietary modification can result in
improved mental health outcomes is further supported
by data from a large European study. The Spanish SUN
Cohort study demonstrated an inverse association be-
tween the level of adherence to a Mediterranean dietary
pattern and the risk for incident depression over approxi-
mately four years in more than 10,000 middle-aged profes-
sionals [28]. Importantly, these data did not support the
reverse causality hypothesis -that depression causes poor
dietary choices. Coupled with significant findings observed
in other studies conducted around the world (Korea,
Greece), these findings suggest a consistent pattern for the
association between diet and mental health in various set-
tings [29,30]. However, the issue of heterogeneity amongst
studies is noted [31].
While the mechanisms underpinning the association
between diet and mental health are not fully understood,
various pathways have been proposed. Diet modulates
several key biological processes that underscore mood dis-
orders, including brain plasticity and function, the stress
response system, mitochondria, inflammation, and oxida-
tive processes [32,33]. A Western dietary pattern is associ-
ated with increased markers of systemic inflammation
[34]. Further, an aetiological role for inflammation in the
pathophysiology of depression is suggested by recent data
showing that higher levels of serum high-sensitivity C-
reactive protein (a marker of systemic inflammation) is anindependent risk factor for a depressive episode [35].
Among people suffering from depression, systemic im-
mune activation, characterised by increased levels of
pro-inflammatory cytokines [36,37] and alterations in
the acute phase protein response [38], have been observed.
Another aspect of consideration, is that a wholefood diet
provides protein and essential fatty acids, in addition to a
range of micronutrients that are critical in neurochemical
function, including B vitamins, zinc, magnesium, vitamin
C, and a range of plant compounds such as flavonoids that
are potent antioxidants and anti-inflammatories [39-41].
Altering dietary patterns may affect a variety of factors
influencing the development and trajectory of depression
[42]. While epidemiological data appear persuasive, cur-
rently no robust study has been conducted exploring the
therapeutic impact of dietary changes on any diagnosed
mental illness. Recent encouraging data suggests that
dietary modification can reduce the risk of cardiovascu-
lar disease [34]. There are encouraging signs in a pilot
randomised controlled study by McMillan et al. [43] that
evaluated the effects of dietary change on mood and
cognition in healthy individuals. The study examined
10 days of adherence to a nutrient-rich diet, compared
to no dietary change in 25 young female adults. The
dietary change group showed significant improvements
in self-rated vigour, alertness and contentment compared
to the control group. Other studies comprising depressed
populations have demonstrated the benefits of dietary
modification using supplements such as omega 3 polyun-
saturated fatty acid (PUFAs) on mood outcomes. Recent
meta-analyses [44-46] have highlighted the benefits of
PUFAs (in particular eicosapentaenoic acid) in those with
depression; specifically, for those with greater symptom
severity. However, high heterogeneity of the studies was
observed.
While these emerging data provide potential validity for
the role of dietary and nutritional factors in the genesis of
depression and its management, it should be acknowl-
edged that currently, there is minimal evidence for dietary
modulation as a treatment for depression. A current clin-
ical trial [47] is however underway to test this hypothesis
by assessing the effect of a prescriptive diet versus an
inactive control (befriending). The results of the RCT are
due in 2015. Regardless of the current deficit of empirical
evidence for prescriptive dietary advice to treat depression,
it is recognized that diet has a major impact on comorbid
medical conditions that are exceedingly more common in
people diagnosed with depression, including cardiovascu-
lar disease and metabolic disorders [48], and the precau-
tionary principle should guide practice.
Physical activity and exercise
Modernity has similarly reduced the amount of work- and
leisure-time physical activity (PA) and formalized exercise
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increasingly sedentary, with the resultant side-effect of
obesity currently recognized as a major health problem
worldwide [49,50]. Epidemiological studies have shown
that adequate PA (based on clinical guidelines) is asso-
ciated with fewer depressive symptoms, while insuffi-
cient PA may be a risk factor for the development of
depressive symptoms [51-54]. This risk factor may be
best modified in early development, [55] as regular PA
in childhood is associated with reduced risk of devel-
oping depression in adulthood. This effect was found
even after adjusting for adult PA. Pasco et al. [56] also
showed a similar protective effect of PA in the elderly.
Not all studies have found such as association: a longi-
tudinal analysis (1991–2002) of the effects of exercise
on depressive symptoms among 5952 genetically iden-
tical twins (aged 18–50) showed that an increase in
exercise participation did not predict fewer depressive
symptoms [57].
Aside from general PA having a potential relationship
with mental health, formalised exercise appears to be an
effective mood elevator [58-60]. Exercise is also a relatively
cheap and safe intervention that has been shown to pro-
vide a range of additional health benefits [61]. Aside from
exercise providing marked beneficial effects on neuroen-
docrine systems, it also increases self-efficacy and self-
esteem (via activity scheduling and attainment of goals)
which are important psychological issues among people
who are depressed [62]. Furthermore, exercise may have
additional beneficial effects by increasing social engage-
ment and enhancing body image.
Exercise has been shown to moderate a range of bio-
logical pathways including: inflammatory cytokines, oxi-
dative stress, neurotrophins and neurogenesis [32,63].
In animal models, exercise has demonstrated biological
effects via multiple mechanisms, including increased levels
of brain derived neurotropic factor (BDNF) [64,65], and
enhanced neurogenesis [66]. Modulation of monoamine
systems has also been shown, with PA increasing expres-
sion of 5HT in animal models [67], and this is theorised to
explain some of the antidepressant effect of exercise [60].
The long-term chronic effects of regular exercise may
assist in regulating the neuroendocrine axis and pro-
duce a normalisation of cortisol levels [68], while in-
creasing circulating beta–endorphins [69] (for a review
see Moylan et al. 2013) [70].
Evidence provides some support for the use of exercise.
A recent Cochrane review (updated from 2009) included
32 studies (n = 1858) involving exercise for the treatment
of researcher-defined depression [71]. From these studies,
28 RCTs (n = 1101) were included in a meta-analysis
revealing a moderate to large effect in favour of exercise
over standard treatment or control. However, only four
trials (n = 326) with adequate allocation concealment,blinding and ITT analysis were located, resulting in a
more modest effect size in favour of exercise. Pooled
data from seven trials (n = 373) with long-term follow-up
data also found a small clinical effect in favour of exercise.
Adequate PA and exercise is of synergistic relevance
given the increased burden of obesity and the metabolic
syndrome in individuals with psychiatric disorders [48],
and the well-established benefits of PA in those comor-
bid health conditions. Currently, the balance of evidence
supports the use of exercise of adequate intensity and dur-
ation to improve mood and reduce depressive symptoms
and comorbid medical disorders.
Another form of exercise that combines a “mindfulness”
element (discussed further below), is the practice of
yoga. A recent systematic review located 12 RCTs (pooled
n = 619) [72]. For effect on the severity of depression,
there was moderate evidence showing a beneficial short-
term effect of yoga compared to usual care, and limited
evidence compared to relaxation, and aerobic exercise.
Aside from the physiological benefits from yoga, the
mindfulness component may also provide a form of focus
that may quell rumination (which is common in depres-
sion). It should be noted that while yoga is gaining in-
creased popularity in the Western world, its safety needs
to be considered. While Yoga is regarded as generally safe,
a previous review has revealed 76 cases of adverse events
from its practice [73]. Due to this, yoga should be prac-
ticed carefully under the guidance of a qualified instructor.
Mindfulness meditation
Meditative practices may also have an application in im-
proving mood and preventing the tumescence of a depres-
sive episode. While the concept of meditation is varied, it
can be categorized into “open monitoring” or “focused”
forms. A key aspect of meditative practice involves mind-
fulness, commonly defined as the awareness which arises
through “paying attention in a particular way: on purpose,
in the present moment, and non-judgmentally” [74]. The
use of meditation as a Western behavioral intervention
was pioneered by Kabat-Zinn [75], with the formal
training program known as Mindfulness-Based Stress
Reduction (MBSR). The practice of MBSR is centered
on an 8–10 week structured program which involves (a)
training in mindfulness meditation practice, (b) mindful
awareness e.g. during yoga postures, and (c) mindful-
ness during stressful everyday situations and social
interaction. Meditative practices such as MBSR can be
readily incorporated into people’s lives, and requires
only basic training (although more advanced traditional
techniques, or modern techniques involving CBT, can
also be taught).
Regular meditation has been shown in various neuro-
imaging studies to affect a range of biological changes
such as, alterations in gray matter morphology, increased
Sarris et al. BMC Psychiatry 2014, 14:107 Page 5 of 13
http://www.biomedcentral.com/1471-244X/14/107cortical thickness in the prefrontal cortex (PFC) and right
anterior insula, increased oxygenated haemoglobin in
the anterior PFC, and elevations in whole blood sero-
tonin (5-HT) levels [76,77]. Electroencephalographic (EEG)
studies have revealed a significant increase in alpha and
theta activity during meditation [78]. Evidence supporting
mindfulness is growing, with a review and meta-analysis
of the intervention for anxiety and mood reduction reveal-
ing a large effect size on improving mood symptoms for
participants receiving mindfulness-based training [79]. It
should be noted that the quality of most studies are poor,
and it is often difficult to ascertain which form/s of medi-
tation is more appropriate for use in depression.
Management of recreational substances (alcohol, cigarettes,
caffeine)
Epidemiological studies and community surveys indicate
that alcohol abuse and dependence commonly co-occur
with affective disorders. Although the specific mecha-
nisms of the associations are still being elucidated [80],
acute alcohol use increases release of monoamines [81].
While acute alcohol use reduces neuronal glutamate
release, during alcohol withdrawal (colloquially known
as the “hangover” stage) a greater amount of rebound
glutamate is released from the synapses and in combin-
ation with dysregulated monoamine and neuroendocrine
pathways, may provoke anxiety and dysphoria [81]. A
meta-analysis of four large-scale epidemiological studies
found a two- to three fold increased lifetime risk for
both depressive and anxiety disorders in those with alco-
hol dependence or abuse [80]. This has been further
supported by a more recent meta-analysis which found
that the presence of either an alcohol use disorder or
major depressive disorder doubles the risk of the other
disorder [82]. There is also data from prospective com-
munity studies that shows heavy use of alcohol in ado-
lescence and young adulthood predicts later onset of
major depressive disorder [83]. Further, harmful or haz-
ardous alcohol use (defined by ICD-10 criteria) when
compared with light drinkers in early adulthood predicts
greater depressive symptomatology, even after control-
ling for confounding factors [84]. Several studies have
shown that depressed mood is substantially alleviated
within a very short time after abstaining from alcohol
[85-87]. A study of 235 women with postpartum depres-
sion who were consuming above recommended levels of
alcohol, found a brief alcohol intervention (two clinician-
guided sessions providing safe drinking guidance and
homework tasks), to be effective at reducing depressive
symptoms (compared with no treatment intervention) at
six-months following the intervention [88].
Smoking cigarettes increases the risk for the genesis of
affective and anxiety disorders [89-93] and appears to be
a potential risk factor for the development of de-novodepression [94]. Cigarette smoking in adolescence may
also increase the risk of the later development of clinic-
ally significant depressive symptoms [95]. There is a risk
of escalation of smoking in people with depression [91],
with some evidence for the existence of a shared genetic
vulnerability to both smoking and depression [96]. In
both unipolar depression and bipolar disorder (but per-
haps not schizophrenia), smoking has not only a dele-
terious effect on symptom severity [97], but may also
interfere with response to treatment [98,99]. A greater
risk of continued smoking and lower abstinence rates
may also be associated with sub-threshold depressive
symptoms [100]. Smoking for some may be a form of
self-medication for acute dysphoric symptom reduction
[91,101]. Regular smokers can be viewed as being in a
persistent dysphoric withdrawal state, punctuated by
brief intoxications when ingesting nicotine. A key neuro-
biological mechanism linking smoking and mood involves
the dopaminergic system, which is implicated in addiction.
Aside from involvement in the regulation of mood, dopa-
mine has a crucial role in the reward/addiction pathways
[102]. As mentioned above, depression can be seen as hav-
ing an inflammatory component, and smoking also aggra-
vates inflammation and provokes marked oxidative stress
[103]. Additionally, evidence from a cross-sectional study
indicates that second-hand cigarette smoke is positively
associated with depressive symptoms in smoking-naive
people (even after adjustment for age, race/ethnicity,
gender, education, alcohol consumption, and medical
comorbidities) [104].
Caffeine is in many cultures the most commonly used
psychoactive substance. It acutely increases attention,
alertness, cognition and mood, with some individuals with
dysphoric mood being predisposed to use caffeine more
heavily, due to its mood-elevating potential (via activation
of noradrenergic and dopaminergic pathways) [105]. Caf-
feine modulates the adenosine system, and the anxiogenic
potential of caffeine is influenced by polymorphisms of the
A2A receptor [106]. There is a suggestion of dysregulation
of the adenosine system in depression [107]. While evi-
dence supports the avoidance of caffeine in anxiety disor-
ders [108], data suggests that caffeine use from coffee
consumption may be protective against depression. A pro-
spective longitudinal analysis (1996–2006) of 50,739 US
women (mean age, 63 years) who were free of depressive
symptoms at baseline, found that there was a reduced risk
of diagnosed depression at follow up for those consuming
two to three cups per day compared to those consuming
one or less per week [109]. This effect was even slightly
stronger in those consuming over four cups per day. Inter-
estingly, decaffeinated coffee was not associated with de-
pression risk. Regardless, there is the potential for people
with high caffeine use affecting insomnia, and this in turn
may increase risk or aggravation of depressed mood [110].
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popular, and there is a suggestion, albeit methodologic-
ally preliminary, of an association of use with mood
disorders [111-113].
Sleep
A good night’s sleep is critical for mental and physical
health, and affective disorders are associated with major
disturbance in circadian rhythm [114,115]. Sleep disturb-
ance is a frequent symptom of depression, and a strong
causal link exists between insomnia and depression [116].
Further, residual sleep difficulties may be predictive of
subsequent depression relapse. It is likely that this is bidir-
ectional; that is, insomnia can increase depression risk and
vice versa. Research has shown that people with chronic
insomnia have an increased risk of a major depressive dis-
order. Cross-sectional data of 2,619 individuals from the
Netherlands Study of Depression and Anxiety (NESDA)
revealed that people with a current depressive or anxiety
disorder, or remittent depression had a significant associ-
ation with sleep disturbance. Interestingly, sociodemo-
graphic factors and psychotropic medication use was not
found to contribute to sleep outcomes [117]. A review of
21 prospective studies with follow-up data by Baglioni
[118] found that insomnia predicted two-fold increased
risk for a depressive episode. Epidemiological data have
shown that approximately 40% of chronic insomniacs suf-
fer from another comorbid psychiatric disorder [10]. Aside
from poor sleep affecting mood, data from the Behavioral
Risk Factor Surveillance System of 138,201 individuals
found that sleep disturbance is a significant risk factor for
myocardial infarction, stroke, obesity, diabetes, and coron-
ary artery disease [119].
Current treatment strategies are mainly based on sleep
hygiene techniques and cognitive behavioural techniques;
and via the use of hypnotic or antidepressant medications
[120]. Additionally, the use of lifestyle modification pro-
grams may improve sleep by addressing factors associated
poor sleep e.g. sedentary life, poor diet, caffeine and alco-
hol use. Merrill and colleagues [121] analyzed data from a
lifestyle change program involving 2,624 individuals aged
30 to 80 years from the Illinois USA area. Participants
were assessed at baseline and then again after four weeks
of completing a 40 hour program which educated them
on making long-term improvements in nutrition and
physical activity and sleep habits. While the study was
uncontrolled and the assessments were potentially open
to bias (thus caution in interpreting this study is ad-
vised), results revealed that of the 10% of participants
who were experiencing insomnia, 64% no longer had a
sleep disturbance at the conclusion of the study. In-
creased PA and a lowering of BMI and caffeine con-
sumption was associated with improved sleep. Changes
in alcohol consumption and smoking however werenot found to significantly contribute to improvement
in sleep.
Social interaction
Another key lifestyle influence affecting mental health
concerns a person’s social environment. Positive, support-
ive, intimate relationships, be it via family, friends or a
relationship, have been established to have a beneficial
effect on general health, and in particular for maintaining
psychological health [122]. Ibarra-Rovillard and Kuiper
[122] propose that the extent to which social relationship
partners are perceived to fulfill (or undermine) basic psy-
chological needs serves to explain both the positive and
negative effects on the well-being of depressed individuals.
Data from the English Longitudinal Study of Aging, ob-
served whether baseline positive and negative exchanges
with partners, family and friends were linked to two-year
changes in depression [123]. Results showed that after
adjusting for confounding factors, negative, but not posi-
tive, exchanges with family and friends were associated
with greater occurrence of depression. A positive relation-
ship has also been shown between social support and
leisure time physical activity (LTPA) [124]. A prospective
cohort study of 5395 middle-aged adults participating in
the British Whitehall II study found that amongst partici-
pants who reported recommended levels of LTPA at base-
line, adults who experienced high emotional support were
more likely to report recommended levels of LTPA at
follow-up. These findings suggest that the enhancement of
social networks and increased social support may help the
individual to maintain the recommended level of LTPA.
While adequate LTPA may potentially provide a psy-
chologically beneficial effect, data is needed assessing
its relation to depression.
Lifestyle elements with emerging data
Recreation and relaxation
A vital lifestyle element in the management of depression
is the pursuit of balancing the “work-rest-play” dynamic.
While the specific effect of pleasurable recreational activ-
ities as a treatment for clinical depression per se has not
been adequately evaluated, it is plausible that this is a
meaningful consideration. Recreational activities provide
an opportunity to experience pleasure, to direct the mind
away from rumination and worry, and may provide a
setting for increased social interaction. The benefits of
participation in organised physical recreation have been
investigated as one strategy for enhancing mental health
and wellbeing. As Street, James and Cutt comment [125],
evaluations by government departments in Australia and
the US have found that people who participate in orga-
nised recreational activity enjoy better mental health, are
more resilient against the stresses of modern living, with a
reduction of depressed mood also evident; however the
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mon form of inexpensive recreation involves listening to
music. Studies of varying methodological quality have
been conducted assessing this for reducing depressive
symptoms [126]. A systematic review of 17 studies found
that listening to music over a period of time helps to re-
duce depressive symptoms in adults. No specific type of
music was found to be superior, with personal preference
recommended.
Aside from recreational activities that may provide
psychological relaxation, formalized relaxation tech-
niques may also be incorporated into people’s lifestyle.
A Cochrane Review and meta-analysis by Jorm and col-
leagues [127] of 11 trials using relaxation techniques (pro-
gressive muscle relaxation, relaxation imagery, autogenic
training) versus control (wait-list, no or minimal treat-
ment), found that although clinician-rated outcomes were
non-significant, self-rated depressive symptoms were re-
duced, with a moderate effect size reported. Specifically, a
meta-analysis of five trials found that relaxation reduced
self-reported depression compared to wait-list, no treat-
ment, or minimal treatment post intervention (although
these are not optimal control conditions). It should also
be noted a meta-analysis of nine trials revealed that relax-
ation produced less effect than psychological interventions
on self-reported depression.
Environmental factors
A range of transpersonal elements are modifiable factors
that may have effects on mental health and depression.
External factors that may affect health can be categorized
into environmental: nature/greenspace; climate, season,
pollution (noise, air and water quality, chemical exposure)
and social: interaction with family, friends and relation-
ships, and a therapeutic association with animals or pets.
It should be noted that while there is evidence of social
interaction and support being potentially protective in
depression (discussed above), there is currently only weak
evidence regarding the other elements.
Adequate exposure to nature (greenspace) may provide
theoretical benefits for general health. Although being
close to greenspace may not necessarily be correlated with
increased PA, studies have shown a relationship to a range
of positive health effects [128]. The benefits of spending
time in nature may also involve increased exposure to fresh
air and sunlight. While the evidence of specific health ben-
efits from “nature-assisted” therapy (for example nature
hikes) is unclear due to a deficit of rigorous studies, the
extant evidence suggests a therapeutic effect. A systematic
review by Annerstedt and Wahrborg [129] found that for
studies of moderate to low evidence grade, health im-
provements were reported in 26 out of 29 studies. Exercis-
ing in nature also may synergistically increase wellbeing
beyond PA in an urban setting [130].It is a commonly held belief that people feel better
“when the sun is shining”, however whilst acute exposure
to sunlight and a pleasant temperature may anecdotally
enhance mood, there appears to be an inconsistent rela-
tionship between seasonal variations and the prevalence of
depression [131,132]. The beneficial effect of sunlight
exposure on mental health has been suggested to be medi-
ated, in part, by vitamin D [133]. However recent research
involving 198 people with multiple sclerosis who were
followed prospectively for an average of 2.3 years, showed
that greater exposure to sunshine may decrease depressive
symptoms, despite no correlation to vitamin D levels
[134]. Low levels of vitamin D appear to be associated
with depression risk, although there is conflicting evidence
as to the effects of supplementation on improving mood
[33,133,135]. Currently, the breadth of evidence provides
inconsistent support for the use of vitamin D supplemen-
tation for depression.
Other environmental factors that are under current
investigation pertain to noise pollution, and exposure to
technological devices. While no direct link to depres-
sion has been documented, continual hyperstimulation
is a theoretical concern for both cognition and mental
health. Environmental toxins (including particulate air
pollution) are also an issue, having a potential effect on
the central nervous system [136]. Emerging evidence
suggests that air pollution may induce neuroinflammation,
oxidative stress, microglial activation, cerebrovascular dys-
function, while potentially altering the blood–brain barrier
[136]. A recent novel mouse model study investigated
whether long-term (10 months) exposure to ambient fine
airborne particulate matter compared to filtered air, affects
affective and cognitive responses [137]. Results revealed
that mice exposed to long-term air pollution displayed
more depressive-like responses and impairments in spatial
learning and memory compared with mice exposed to
filtered air. Exposure to air pollution has been found to
be associated with an increase in depressive symptoms
in a longitudinal study of 537 elderly Koreans [11].
However, the evidence currently does not clearly con-
firm the relationship between pollution and depression,
with NHANES data (unpublished) failing to demonstrate
a consistent relationship between persistent organic and
heavy metal pollutants and depression.
Animal and pet therapy
Humans commonly have close relationships with animals,
particularly pets, and such relationships may have a theor-
etical benefit for alleviating depressed mood. Having a pet
can provide physical affection and a feeling of uncondi-
tional love, assist in the maintenance of a routine, and
also provide responsibility and an additional sense of life
purpose. Formalized animal-assisted therapy may involve
horses (equine therapy), dogs, or even interactions with
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by people with psychiatric disorders may reduce depres-
sion and state anxiety, and increase a sense of self-efficacy
[138], with a small and methodologically limited study
suggesting beneficial effects of pet therapy on mood and
perceived quality of life in 21 elderly inpatients affected by
dementia, depression and psychosis [139]. No clinical rec-
ommendations are possible given the available data.
Clinical considerations
The application of Lifestyle Medicine should be consid-
ered in the context of long-term sustainability. Motiv-
ational issues, time restrictions, financial limitations,
the perspective about the source of their difficulties and
treatment priorities, may influence a patient’s ability to
implement lifestyle changes. Adherence and engage-
ment are increased by having ownership of a treatment
plan and a sense of shared partnership in its development
and planning. Treatment strategies should therefore be
developed taking cognisance of the above factors, and
the treatment package should be individually tailored
and offered in a step-wise manner. It is also necessary
to consider readiness to change when engaging in dis-
cussion regarding lifestyle modification, and concordant
with the transtheoretical model, to only embark on this
when the person has moved beyond precontemplation
to the contemplation or preparation stages [140]. Some
lifestyle choices and “vices” may provide the person self-
perceived support and comfort, and in such cases change
needs to be handled delicately. Often, strict advice pro-
moting abstinence, or a demanding diet or exercise re-
gime, may cause added suffering, and may also provoke
guilt if the person cannot meet these expectations, or
lead to paradoxical behaviour if oppositional cognitive
schema are activated.
With respect to specific dietary advice, it is important
to recognise that the nutrients critical for neurological
function (magnesium, folate, zinc and essential fatty acids),
and are all components of a healthy diet, found primarily
in foods such as leafy green vegetables, legumes, whole-
grains, lean red meat and fish. Foods rich in polyphenols
(e. g. berries, tea, dark chocolate, wine and certain herbs),
are also valuable for cognitive and cardiovascular function
[141,142]. Aside from having adequate wholefoods, people
are also advised to reduce processed foods, refined carbo-
hydrates and sugars, and transaturated fats. Adherence to
the Mediterranean diet has also been shown to be associ-
ated with a range of mental health benefits.
Regarding the dosage and type of exercise to recom-
mend, research indicates that a dose-dependent effect oc-
curs, with regular moderate to strong intensity exercise
eliciting more positive results [143,144]. Clinical guidelines
for exercise recommend physician assessment (or refer-
ral to an exercise physiologist) before commencing anew regime, which should consist of moderate to vigorous
aerobic exercise (30–60 minutes) in addition to anaerobic
weight-bearing exercises approximately four to six days
per week [145,146]. Exposure to social interaction and
nature when exercising may be useful on theoretical
grounds.
The integration of meditative practices can be readily
incorporated into most people’s lifestyle. While regular
formal practice of meditation or yoga can be recom-
mended, it can be applied in simple forms, such as
mindful walking or eating, or yoga breathing exercises.
With respect to yoga, it is advised that people pursue
instruction under a qualified instructor, and proceed in a
graded manner; as is the case for all forms of exercise.
Patients with glaucoma (with any inverted poses), osteo-
porosis (with any heavy weight-bearing pose), should
proceed with caution.
Due to the potential impact of heavy alcohol use on
the risk and treatment for depression [147,148], routine
clinical questioning about alcohol consumption is appro-
priate. In a clinical setting, the focus should be on differ-
entiating and managing problem drinking (where it is
identified), and on psycho-education of patients regard-
ing modest alcohol consumption and avoiding heavy
episodic drinking. Further education may be required
regarding potential interactions between alcohol use
and medications. Techniques combining motivational
interviewing and cognitive behavioural therapy may be
of benefit in treating the dual components of depression
and problem drinking [149,150].
Smoking cessation should also form a routine component
of clinical care, with individuals being offered evidence-
based smoking cessation interventions when appropriate
[151]. Interestingly, PA used concurrently with smoking
cessation seems to be protective against relapse in quit-
ters, further reinforcing recommendations regarding ex-
ercise [152]. One caveat is required: the act of cessation
is associated with withdrawal symptoms including tran-
sient dysphoria, irritability and a risk of aggravation of
depression [153]. However, once the neurochemical set-
point has re-adapted to the absence of nicotine, this
should normalize. While trials of smoking cessation that
examine long term change in depression risk have not
been conducted, recent data suggests that quitting
smoking is associated with better social functioning and
self-perceived health status [154].
Sleep hygiene techniques that can be offered in the case
of poor sleep or insomnia, includes focusing on adjusting
caffeine use, limiting exposure to the bed (sleep restric-
tion) with the patient having only a limited time to sleep,
and getting up at a set time in the morning [155]. This
should regulate the circadian rhythm, which is of particu-
lar significance in people with affective disorders [115].
Reducing exposure to light prior to sleep to increase
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increased exposure to morning sunlight upon waking.
Further sleep hygiene advice includes stimulus control:
avoidance of stimulating activity and stimulants close to
sleep (for example, smoking, caffeine and stimulating
TV or books), and quiescent sleep preparation. Although
evening meal portions should not be excessive (this may
cause rebound hypoglycaemia), sufficient calorific intake is
required to avoid waking up due to hunger.
Other lifestyle targets can consist of emphasising the
importance of social contact, and the theoretically positive
benefits of animals/pets [122,139]. The therapeutic bene-
fits of spending time in nature is supported by a limited
dataset [129]. Adequate exposure to sunlight should
enhance vitamin D levels and serotonin turnover [157],
however this needs to be balanced with concerns over
skin cancer, thus time of day/year and skin colour are
factors in consideration about the amount of sun ex-
posure recommended. While current data are weak
with respect to an association with depression, limited
exposure to environmental toxins, chemicals pollut-
ants [136] and noise pollution [158], is also a valid gen-
eral health consideration. While limited study in this
area has been pursued and there is no direct link to de-
pression, moderation of excessive technological inter-
face (e.g. mobile phones, computers, television) is also
a potential consideration in Lifestyle Medicine [2].
Summary
While many factors, including genetics, personality and
cognition, and environmental stressors contribute to the
aetiology of depression, lifestyle components may have an
important role in the disorder’s pathogenesis. Currently,
the contemporary clinical management of depression has
had more of a focus on medication and psychotherapy,
and to date, has not widely incorporated the evidence re-
garding many lifestyle factors into guidelines. As outlined
above, there is evolving evidence to support the modifica-
tion of selected lifestyle elements. Further research is now
needed to study “integrative models” assessing the applica-
tion of prescriptive Lifestyle Medicine, similar to those
used in other medical populations [159]. Trial designs
could explore individualized tailored programs, or the
step-wise application of individual components according
to patient interest or need. While the study would not be
double-blinded, it is possible to randomize participants
into the active lifestyle modification group versus a pla-
cebo or inactive group, with the outcomes being assessed
by an independent blinded researcher (using validated psy-
chiatric scales). Further work exploring the mechanistic
underpinnings of lifestyle modification is also of benefit.
In future respect to the research underpinning lifestyle
modification for depression, aside from prospective RCTs
needing to assess some lesser studied lifestyle elementssuch as dietary modification, one critical area of study is
to explore the effects of an integrated multi-faceted appli-
cation of lifestyle medicine. To date, to our knowledge
only one RCT has examined the effects of combining mul-
tiple lifestyle adjustments for the treatment of depression.
Garcia-Toro and colleagues [160] conducted an RCT of
80 outpatients with diagnosed major depressive disorder
(non-SAD) who were taking antidepressant treatment.
Four specific lifestyle recommendations consisting of diet-
ary modification, exercise, sunlight exposure and sleep
patterns were prescribed in the active group, while the
control group was given instruction to perform a pattern
of eating, sleeping, exercise and exposure to light which
they considered might make them feel better. Blinded
assessment was conducted before and after the six month
intervention period. The active group had a significantly
greater reduction of depression than the control group,
with 11 out of 40 people (28%) in the active group achiev-
ing remission (HAM-D < 7), compared to only one person
in the control group. These encouraging results are in line
with remission rates of standard antidepressants, and
support the conduct of similar more definitive studies.
Conclusions
In conclusion, a variety of lifestyle modifications exist
that have appropriate potential front-line clinical appli-
cation alongside pharmacotherapies and psychological
techniques to better manage depression. While the judi-
cious use of medication and psychological techniques are
still advocated, due to the complexity of human illness/
wellbeing, the time has come for a more integrative
approach for depression, and an acknowledgment of the
potential applicability of lifestyle modification.
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